Oct 2026· European Heart Journal· Vol 47· 0 citations
TL;DR
Let-7b-5p is identified as a novel protective regulator that safeguards the aorta by suppressing VSMC PANoptosis and suggesting that targeting the let-7b-5p axis may offer a potent therapeutic strategy to limit pathological remodeling and preventing AD.
Abstract
Vascular smooth muscle cell (VSMC) loss is a hallmark of aortic dissection (AD) pathogenesis. Emerging evidence suggests that PANoptosis, a unique inflammatory cell death mechanism involving apoptosis, necroptosis, and pyroptosis, drives medial degeneration. While microRNAs are essential post-transcriptional regulators, the specific contribution of let-7b-5p to VSMC PANoptosis and AD pathogenesis remains poorly defined.
This study aimed to investigate whether let-7b-5p protects aortic integrity by modulating PANoptotic signaling.
AD was induced in mice using β-aminopropionitrile fumarate (BAPN) and Angiotensin II (Ang II). To assess therapeutic efficacy, mice were administered subcutaneously with let-7b-5p mimics or negative controls. Survival rates, AD incidence, and vascular morphology (H&E, EVG staining) were evaluated. The expression of PANoptotic executioners (CASP3, NLRP3, and MLKL) was quantified in the aortic media.
In murine AD models, let-7b-5p expression was significantly downregulated, correlating with a robust increase in CASP3, NLRP3, and MLKL within the medial layer. Restoration of let-7b-5p significantly improved animal survival and decreased AD incidence. Histological analysis revealed that let-7b-5p overexpression markedly attenuated elastic fiber breakage, pseudolumen formation, and inflammatory cell infiltration. Furthermore, let-7b-5p delivery effectively suppressed the activation of PANoptosis-related markers in the aortic wall, preserving the VSMC population and structural stability.
Our findings identify let-7b-5p as a novel protective regulator that safeguards the aorta by suppressing VSMC PANoptosis. These results suggest that targeting the let-7b-5p axis may offer a potent therapeutic strategy to limit pathological remodeling and preventing AD.Scheme
Introduction:
Thoracic aortic dissection (TAD) is a highly lethal cardiovascular disease characterized by progressive aortic wall degeneration and smooth muscle cell (SMC) loss. Necroptosis, a regulated form of inflammatory cell death mediated by RIPK3 and MLKL, has been implicated in cardiovascular injury, but its...
Sanjib Sarkar, Kimberly R. Rebello, Lin Zhang et al.· Circulation· 0 citations
Background:
Thoracic aortic dissection (TAD) is a life-threatening vascular disease marked by medial degeneration, vascular smooth muscle cell (VSMC) loss, and extracellular matrix disruption, yet its underlying mechanisms remain poorly understood. Cyclin Y (CCNY), a cyclin family member involved in cellular homeost...
Adventitial inflammation is involved in the onset of Takayasu arteritis (TAK) and the formation of pathological conditions. E4BP4 (also known as NFIL3) is a basic leucine zipper (bZIP)-type transcription factor associated with circadian rhythms and cell viability, and previous in vitro studies have demonstrated t...
T. Niida, F. Ohtomo, T. Kadoguchi et al.· European Heart Journal· 0 citations
BACKGROUND
Perivascular adipose tissue (PVAT) is the endocrine microenvironment closest to the aorta. Using multiomics analysis, we found that Cers6 (ceramide synthase 6) was upregulated and C16:0 ceramide accumulated in thoracic aortic PVAT (taPVAT) from aortic dissection (AD) mice; however, its role and underlying me...
Xing-Hui Zhuang, Zong-Sheng Jiang, Hao-Yu Li et al.· Arteriosclerosis, Thrombosis...· 0 citations
The nuclear receptor NOR-1 is a key transcription factor in vascular smooth muscle cells (VSMCs) implicated in the pathogenesis abdominal aortic aneurysm (AAA), a life-threatening disease lacking pharmacological options. Here, we aimed at identifying potential therapeutic targets regulated by NOR-1 in the onset and pro...
Paula Vázquez-Sufuentes, J. Alonso, R. Almendra-Pegueros et al.· Translational Research: The...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.